Bepridil

Bepridil (trade name Vascor) is an amine calcium channel blocker once used to treat angina. It is no longer sold in the United States.

Bepridil
Clinical data
Trade namesVascor
AHFS/Drugs.comMonograph
MedlinePlusa699051
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration
    Oral
    ATC code
    Pharmacokinetic data
    BioavailabilityWell absorbed
    Protein binding99%
    MetabolismHepatic, CYP3A4-mediated
    Elimination half-life42 hours
    ExcretionRenal
    Identifiers
    CAS Number
    PubChem CID
    IUPHAR/BPS
    DrugBank
    ChemSpider
    UNII
    ChEBI
    ChEMBL
    CompTox Dashboard (EPA)
    Chemical and physical data
    FormulaC24H34N2O
    Molar mass366.54 g/mol g·mol−1
    3D model (JSmol)
      (verify)

    It is nonselective.[1]

    It has been discussed as a possible option in the treatment of atrial fibrillation.[2]

    It has been implicated in causing ventricular arrhythmia (torsades de pointes).

    Ebola research

    In June 2015 a research paper [3] was published finding bepridil to result in a 100% survival rate for mice exposed to ebola during an experiment searching for potential pharmaceutical ebola treatments; indicating its potential use in future ebola research and therapy.[4]

    References


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.